Sanofi Income from Continuous Operations 2010-2024 | SNY

Sanofi income from continuous operations for the twelve months ending September 30, 2024 was $4.961B, a 49.27% decline year-over-year.

  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
  • Sanofi annual income from continuous operations for 2022 was $8.939B, a 20.33% increase from 2021.
  • Sanofi annual income from continuous operations for 2021 was $7.429B, a 47.34% decline from 2020.

Sanofi Income from Continuous Operations 2010-2024 | SNY

  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
  • Sanofi annual income from continuous operations for 2022 was $8.939B, a 20.33% increase from 2021.
  • Sanofi annual income from continuous operations for 2021 was $7.429B, a 47.34% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk A/S (NVO)$481.1B
Merck & Co., Inc. (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca PLC (AZN)$200B
Pfizer Inc. (PFE)$151.4B
Innoviva, Inc. (INVA)$1.3B